What is the global market size of Genome Editing Market?

The Global Genome Editing Market was valued at USD 5.25 Billion in 2021, and it is expected to reach a value of USD 17.02 Billion by 2028, at a CAGR of 18.30% over the forecast period (2022 - 2028). Read More

Who are the key vendors in the Global Genome Editing Market?

The market's various competitors are challenged to provide innovative offerings that enable communication in addressing changing technologies, business practices, and security needs. Partnerships, strategic mergers, and acquisitions are expected to be the most effective ways for industry players to gain quick access to emerging markets while also improving technological capabilities. Custom vectors for cell line editing and engineering are provided by well-established companies such as Merck KGaA and Thermo Fisher Scientific. Such services are anticipated to grow in the coming years, fueling revenue growth. Contract manufacturers would benefit from the rapidly increasing demand from gene therapy Genome Editing Market players.'Thermo Fisher Scientific (US)','Merck KGaA (Germany)','GenScript (China)','Sangamo Therapeutics (US)','Lonza (Switzerland)','Editas Medicine (US)','CRISPR Therapeutics AG (Switzerland)','Tecan Life Sciences (Switzerland)','Precision Biosciences (US)','Agilent Technologies (US)' Read More

What is the key driver of Global Genome Editing Market?

Governments in various countries around the world have made significant investments in the field of genomics in recent years, which has played a significant role in the development of new technologies in genome editing. Furthermore, the availability of government funding has enabled academic and government institutes to conduct in-depth genome editing/engineering research. For instance, in March 2020, the Ministry of Innovation, Science, and Industry (Science) announced a USD 15 million grant to Genome Canada to support 11 genomic research projects in the health, agriculture, and environment sectors. Provincial governments, businesses, and research partners will also contribute to these projects, with a total investment of USD 29.7 million. Ovarian and cervical cancer research is among the projects. The number of genomics research projects has increased significantly as a result of significant government investments in genomics. As a result, the genome editing market is expected to grow during the forecast period. Read More

What is the key market trend for Global Genome Editing Market?

The COVID-19 pandemic has prompted major pharmaceutical and biotechnology firms, as well as players in the genomic market, to invest in vaccine research and development. The increased demand for vaccines and antiviral candidates has pushed genome editing/engineering technologies to the forefront, these factors are expected to drive the Genome Editing Market in the upcoming years. Read More

Which region accounted for the largest share in Global Genome Editing Market?

North America dominated the genome editing market in 2021, accounting for 38.4% of total revenue. The dominance of the Genome Editing Market in the region is due to the availability of strong research, as well as a commercial base for advanced therapeutic development, as well as a large number of clinical studies being undertaken for gene and stem cell therapies in the region. On the other hand, the market in the Asia Pacific is expected to expand at a rapid rate over the projected period. China unveiled its 10 most significant agricultural breakthroughs in November 2020, one of which was gene-editing technology, demonstrating strong Genome Editing Market penetration. Read More

Genome Editing Companies

Genome Editing Market Competitive Landscape

Genome Editing Market Top Players Company Profiles

Merck KGaA (Germany)
Cibus Inc (US)
Recombinetics (US)
Sangamo Therapeutics (US)
Editas Medicine (US)
Precision BioSciences (US)
CRISPR Therapeutics (Switzerland)
Intellia Therapeutics, Inc (US)
Caribou Biosciences, Inc. (US)
Cellectis S.A (France)
AstraZeneca (UK)
Takara Bio Inc. (Japan)
Horizon Discovery Ltd. (Revvity, Inc.) (UK)
Danaher Corporation (US)
Transposagen Biopharmaceuticals, Inc. (US)
Genscript Biotech Corp (China)
New England Biolabs (US)
OriGene Technologies, Inc. (US)
bluebird bio, Inc (US)
Lonza (Switzerland)
Thermo Fisher Scientific Inc. (US)

Genome Editing Market

FAQs

Global Genome Editing Market size was valued at USD 7.70 billion in 2022 and is poised to grow from USD 8.99 billion in 2023 to USD 31.15 billion by 2031, growing at a CAGR of 16.80% during the forecast period (2024-2031).

One of the most important technical hurdles in genome editing is off-goal consequences, which encompass unintentional adjustments inside the genome. This uncertainty, mainly in the clinical applications, remains a barrier to the adoption of genome change in human medication. These unintended modifications can result in deleterious mutations, raising concerns about the safety of the genome enhancing cures. 'Merck KGaA (Germany) ', 'Cibus Inc (US) ', 'Recombinetics (US) ', 'Sangamo Therapeutics (US) ', 'Editas Medicine (US) ', 'Precision BioSciences (US) ', 'CRISPR Therapeutics (Switzerland) ', 'Intellia Therapeutics, Inc (US) ', 'Caribou Biosciences, Inc. (US) ', 'Cellectis S.A (France) ', 'AstraZeneca (UK) ', 'Takara Bio Inc. (Japan) ', 'Horizon Discovery Ltd. (Revvity, Inc.) (UK) ', 'Danaher Corporation (US) ', 'Transposagen Biopharmaceuticals, Inc. (US) ', 'Genscript Biotech Corp (China) ', 'New England Biolabs (US) ', 'OriGene Technologies, Inc. (US) ', 'bluebird bio, Inc (US) ', 'Lonza (Switzerland) ', 'Thermo Fisher Scientific Inc. (US)'

Genome editing is gaining popularity in agriculture, where it can be used to produce crops with improved traits such as drought tolerance, pest resistance and improved nutrition Agriculture is expected to play an important role in the future genome editing technological advances. CRISPR technology has improved crops rapidly in this market.

Growing Application in Agriculture: Genome editing is gaining popularity in agriculture, where it is used to produce crops with improved traits such as drought tolerance, pest resistance and improved nutrition. CRISPR technology has enabled rapid crop improvement, which is exactly, making it a leading trend in this market. Agriculture is expected to play an important role in the future development of genome editing technologies as global food security concerns rise.

North America is dominated the genome editing market, accounting for 47.81% in 2023 due to rising investments in R&D of gene editing technologies. Several biotechnologies and the pharmaceutical companies operating in the genome editing technology are estimated to remain dominant over the forecast period. Availability of strong research infrastructure, rise in genetically modified crops, high genetic diseases inherited diseases are common. In other words, the number of licenses issued by U.S-based firms. Increased supply has also accelerated the development of genome editing tools in the country, leading to positive market growth.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Genome Editing Market Competitive Landscape

Genome Editing Market Report Snapshots

Want to customize this report?

FAQs

Request Free Customization

Feedback From Our Clients

$5,300

Genome Editing Market Competitive Landscape

Genome Editing Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Genome Editing Market?

Who are the key vendors in the Genome Editing Market?

What is the key driver of Genome Editing Market?

What is the key market trend for Genome Editing Market?

Which region accounted for the largest share in Genome Editing Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300